JP2003518475A5 - - Google Patents

Download PDF

Info

Publication number
JP2003518475A5
JP2003518475A5 JP2001511906A JP2001511906A JP2003518475A5 JP 2003518475 A5 JP2003518475 A5 JP 2003518475A5 JP 2001511906 A JP2001511906 A JP 2001511906A JP 2001511906 A JP2001511906 A JP 2001511906A JP 2003518475 A5 JP2003518475 A5 JP 2003518475A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
phenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001511906A
Other languages
English (en)
Japanese (ja)
Other versions
JP5010788B2 (ja
JP2003518475A (ja
Filing date
Publication date
Priority claimed from DE19935219A external-priority patent/DE19935219A1/de
Application filed filed Critical
Publication of JP2003518475A publication Critical patent/JP2003518475A/ja
Publication of JP2003518475A5 publication Critical patent/JP2003518475A5/ja
Application granted granted Critical
Publication of JP5010788B2 publication Critical patent/JP5010788B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001511906A 1999-07-27 2000-07-22 カルボン酸アミド、その化合物を含有する医薬組成物、その使用及び調製 Expired - Fee Related JP5010788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19935219A DE19935219A1 (de) 1999-07-27 1999-07-27 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
DE19935219.4 1999-07-27
PCT/EP2000/007057 WO2001007020A2 (de) 1999-07-27 2000-07-22 Carbonsäureamide, diese verbindungen enthaltende arzneimittel, deren verwendung und herstellung

Publications (3)

Publication Number Publication Date
JP2003518475A JP2003518475A (ja) 2003-06-10
JP2003518475A5 true JP2003518475A5 (cg-RX-API-DMAC7.html) 2007-09-20
JP5010788B2 JP5010788B2 (ja) 2012-08-29

Family

ID=7916195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001511906A Expired - Fee Related JP5010788B2 (ja) 1999-07-27 2000-07-22 カルボン酸アミド、その化合物を含有する医薬組成物、その使用及び調製

Country Status (27)

Country Link
US (2) US6362210B1 (cg-RX-API-DMAC7.html)
EP (1) EP1261321A2 (cg-RX-API-DMAC7.html)
JP (1) JP5010788B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020032537A (cg-RX-API-DMAC7.html)
CN (1) CN1414849A (cg-RX-API-DMAC7.html)
AR (1) AR024944A1 (cg-RX-API-DMAC7.html)
AU (1) AU6436800A (cg-RX-API-DMAC7.html)
BG (1) BG106343A (cg-RX-API-DMAC7.html)
BR (1) BR0013184A (cg-RX-API-DMAC7.html)
CA (1) CA2378382C (cg-RX-API-DMAC7.html)
CO (1) CO5180639A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2002313A3 (cg-RX-API-DMAC7.html)
DE (1) DE19935219A1 (cg-RX-API-DMAC7.html)
EA (1) EA200200114A1 (cg-RX-API-DMAC7.html)
EE (1) EE200200041A (cg-RX-API-DMAC7.html)
HR (1) HRP20020072A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0204373A3 (cg-RX-API-DMAC7.html)
IL (1) IL147707A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02000822A (cg-RX-API-DMAC7.html)
NO (1) NO20020374L (cg-RX-API-DMAC7.html)
PL (1) PL361335A1 (cg-RX-API-DMAC7.html)
SK (1) SK2962002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200200226T2 (cg-RX-API-DMAC7.html)
UY (1) UY26256A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001007020A2 (cg-RX-API-DMAC7.html)
YU (1) YU5502A (cg-RX-API-DMAC7.html)
ZA (1) ZA200200694B (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645964B1 (en) * 1999-11-29 2003-11-11 Aventis Pharma S.A. Chemical derivatives and their application as antitelomerase agent
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 N-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
DE10065042A1 (de) * 2000-12-23 2002-06-27 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US6887873B2 (en) 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
US20040132807A1 (en) * 2001-04-18 2004-07-08 Dario Ballinari Aurones as telomerase inhibitors
FR2825090B1 (fr) * 2001-05-28 2003-08-01 Aventis Pharma Sa Derives chimiques et leur application comme agent antitelomerase
AU2002314252A1 (en) 2001-05-28 2002-12-09 Aventis Pharma S.A. Chemical derivatives and the use thereof as an anti-telomerase agent
GB0127615D0 (en) * 2001-07-09 2002-01-09 Aventis Pharm Prod Inc Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
MXPA04005427A (es) * 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
US20070232572A1 (en) * 2003-02-07 2007-10-04 Aventis Pharma S.A. Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agent
US7906537B2 (en) 2003-03-21 2011-03-15 H. Lundbeck A/S Substituted p-diaminobenzene derivatives
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
KR20070057965A (ko) * 2004-09-21 2007-06-07 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
US8084492B2 (en) * 2004-11-19 2011-12-27 The New Industry Research Organization Benzofuran compound and pharmaceutical composition containing the same
US20070072873A1 (en) * 2005-09-27 2007-03-29 Henrietta Dehmlow Novel thiophene derivatives which are HM74A agonists
NZ574028A (en) 2006-07-05 2010-10-29 Fibrotech Therapeutics Pty Ltd Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
NZ601866A (en) 2007-06-29 2013-12-20 Acucela Inc Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
MX2010000918A (es) 2007-07-24 2010-03-15 Astellas Pharma Inc Derivado de bencimidazol.
SG10201506526QA (en) * 2007-12-21 2015-09-29 Fibrotech Therapeutics Pty Ltd Halogenated analogues of anti-fibrotic agents
US20110054034A1 (en) * 2008-02-08 2011-03-03 Schroeder Jr William Methods of using carboxylic amides as antimicrobial agents
EP2383573A4 (en) 2009-01-27 2012-10-24 Astellas Pharma Inc SCREENING METHOD FOR A SUBSTANCE USED AS A MEDIUM FOR TREATMENT OF PROSTATE CANCER
WO2010144959A1 (en) * 2009-06-18 2010-12-23 Fibrotech Therapeutics Pty Ltd Analogues of anti-fibrotic agents
EP2947073B1 (en) 2009-10-22 2019-04-03 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
EP2758041B1 (de) 2011-09-20 2021-01-13 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
CN104125947A (zh) * 2011-12-21 2014-10-29 生物区欧洲有限公司 杂环脲化合物
EP3577103A1 (en) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
CN110357789B (zh) * 2018-04-11 2022-09-30 华东理工大学 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
CN114831977B (zh) * 2021-02-02 2023-12-19 北京大学 苯甲酸类衍生物作为trpm2蛋白抑制剂的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640710B2 (cg-RX-API-DMAC7.html) * 1973-01-18 1981-09-22
JPS5848545B2 (ja) * 1974-04-18 1983-10-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
JPS6097946A (ja) * 1983-11-01 1985-05-31 Ono Pharmaceut Co Ltd カルボキサミド誘導体
JPS60139646A (ja) * 1983-12-27 1985-07-24 Otsuka Pharmaceut Factory Inc ナフタレン誘導体
JPS60146855A (ja) * 1984-01-11 1985-08-02 Ono Pharmaceut Co Ltd アニリン誘導体
JPS61170528A (ja) 1985-01-22 1986-08-01 Sutaaroi Sangyo Kk コバルトの剥離回収方法
US5239083A (en) * 1991-03-11 1993-08-24 Kyowa Hakko Kogyo Co., Ltd. Indole derivatives which inhibit steroid 5α reductase
JPH0578315A (ja) * 1991-03-11 1993-03-30 Kyowa Hakko Kogyo Co Ltd インドール誘導体
JPH0672866A (ja) * 1992-07-02 1994-03-15 Chugoku Igakuka Gakuin Yakubutsu Kenkyusho 分化誘導剤
IT1276462B1 (it) 1995-07-03 1997-10-31 Rotta Research Lab Diamidi aromatiche acide ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico
JPH09154575A (ja) * 1995-10-04 1997-06-17 Soosei:Kk テロメラーゼ
IT1286141B1 (it) 1996-07-02 1998-07-07 Rotta Research Lab Derivati diammidici dell'acido antranilico ad attivita' antigastrinica procedimento per la loro preparazione e loro uso farmaceutico.
FR2759368B1 (fr) 1997-02-10 2001-06-01 Galderma Rech Dermatologique Composes biaromatiques, compositions les contenant et utilisations
JPH1149676A (ja) * 1997-07-31 1999-02-23 Geron Corp ピリジン系テロメラーゼ阻害剤
AU8684598A (en) * 1997-08-05 1999-03-01 American Home Products Corporation Anthranilic acid analogs
PT1037880E (pt) 1997-12-11 2004-11-30 Janssen Pharmaceutica Nv Anilidas mimeticas do acido retinoico
CA2338804A1 (en) 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
WO2000026197A1 (en) 1998-10-29 2000-05-11 Bristol-Myers Squibb Company Novel inhibitors of impdh enzyme

Similar Documents

Publication Publication Date Title
RU2458920C2 (ru) Новые соединения
JP2004530656A5 (cg-RX-API-DMAC7.html)
RU2462454C2 (ru) Новое сульфонамидное производное малоновой кислоты и его фармацевтическое применение
JP2006504761A5 (cg-RX-API-DMAC7.html)
JP2004525873A5 (cg-RX-API-DMAC7.html)
JP2003527429A5 (cg-RX-API-DMAC7.html)
JP2004532227A5 (cg-RX-API-DMAC7.html)
JP2003508394A5 (cg-RX-API-DMAC7.html)
CA2299139A1 (en) 4-phenyl-pyridine derivatives
JP2004529931A5 (cg-RX-API-DMAC7.html)
JP2006501292A5 (cg-RX-API-DMAC7.html)
RU2009126624A (ru) Производные 2-(пиперидин-4-ил)-4-фенокси-или фенилаинопиримидина в качестве ненуклеозидных ингибитров обратной транскриптазы
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
CA2445344A1 (en) Heterocyclic compound derivatives and medicines
CA2392570A1 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
JP2006500348A5 (cg-RX-API-DMAC7.html)
IL276946B (en) Antiproliferative compounds and methods of use
RU2011127451A (ru) ПРОИЗВОДНЫЕ ТИЕНО[3,2-c]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ РАКА
RU2008140144A (ru) Азотосодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента
JP2005513052A5 (cg-RX-API-DMAC7.html)
Koltun et al. Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine
JP2011510929A5 (cg-RX-API-DMAC7.html)
ZA200401456B (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases.
NO20062151L (no) Derivater av N-[heteroaryl(piperidin-2-yl)metyl]benzamid, fremgangsmate for fremstilling derav og anvendelse av forbindelsene innenfor terapi
CA2444395A1 (en) Use of nk-1 receptor antagonists against benign prostatic hyperplasia